gitoxin has been researched along with etoposide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, CA; Ayuso, MJ; Azrak, SS; Cortés, F; López-Lázaro, M; Pastor, N | 1 |
| Ayuso, MJ; Cortés, F; López-Lázaro, M; Martín-Cordero, C; Navarro, E; Palma De La Peña, N; Pastor, N; Toro, MV | 1 |
2 other study(ies) available for gitoxin and etoposide
| Article | Year |
|---|---|
Digitoxin inhibits the growth of cancer cell lines at concentrations commonly found in cardiac patients.
Topics: Antineoplastic Agents; Cardiotonic Agents; Digitoxin; DNA Damage; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Molecular Structure; Tumor Cells, Cultured | 2005 |
Anti-tumour activity of Digitalis purpurea L. subsp. heywoodii.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Cardenolides; Cell Line, Tumor; Digitalis; Digoxin; Etoposide; Humans; Inhibitory Concentration 50; Kidney Neoplasms; Phytotherapy; Plant Extracts; Plant Leaves | 2003 |